FR2875512B1 - DIAGNOSTIC BIOPUCE OF METASTATIC OR LOCALIZED CHARACTER OF A MAMMARY TUMOR, METHOD AND KIT OF USE - Google Patents

DIAGNOSTIC BIOPUCE OF METASTATIC OR LOCALIZED CHARACTER OF A MAMMARY TUMOR, METHOD AND KIT OF USE

Info

Publication number
FR2875512B1
FR2875512B1 FR0409862A FR0409862A FR2875512B1 FR 2875512 B1 FR2875512 B1 FR 2875512B1 FR 0409862 A FR0409862 A FR 0409862A FR 0409862 A FR0409862 A FR 0409862A FR 2875512 B1 FR2875512 B1 FR 2875512B1
Authority
FR
France
Prior art keywords
biopuce
metastatic
diagnostic
kit
mammary tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0409862A
Other languages
French (fr)
Other versions
FR2875512A1 (en
Inventor
Valerie Chabaud
Incan Chantal D
Vidal Valerie Sylvain
Veronique Vidal
Marie Agier
Yves Jean Bignon
Christian Pradeyrol
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diagnogene S A
Original Assignee
Diagnogene S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diagnogene S A filed Critical Diagnogene S A
Priority to FR0409862A priority Critical patent/FR2875512B1/en
Priority to PCT/FR2005/002308 priority patent/WO2006032769A1/en
Publication of FR2875512A1 publication Critical patent/FR2875512A1/en
Application granted granted Critical
Publication of FR2875512B1 publication Critical patent/FR2875512B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
FR0409862A 2004-09-17 2004-09-17 DIAGNOSTIC BIOPUCE OF METASTATIC OR LOCALIZED CHARACTER OF A MAMMARY TUMOR, METHOD AND KIT OF USE Expired - Fee Related FR2875512B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR0409862A FR2875512B1 (en) 2004-09-17 2004-09-17 DIAGNOSTIC BIOPUCE OF METASTATIC OR LOCALIZED CHARACTER OF A MAMMARY TUMOR, METHOD AND KIT OF USE
PCT/FR2005/002308 WO2006032769A1 (en) 2004-09-17 2005-09-19 Biochip for diagnosis of the metastatic or localized character of a mammary tumour, method and kit for use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0409862A FR2875512B1 (en) 2004-09-17 2004-09-17 DIAGNOSTIC BIOPUCE OF METASTATIC OR LOCALIZED CHARACTER OF A MAMMARY TUMOR, METHOD AND KIT OF USE

Publications (2)

Publication Number Publication Date
FR2875512A1 FR2875512A1 (en) 2006-03-24
FR2875512B1 true FR2875512B1 (en) 2011-02-04

Family

ID=34948818

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0409862A Expired - Fee Related FR2875512B1 (en) 2004-09-17 2004-09-17 DIAGNOSTIC BIOPUCE OF METASTATIC OR LOCALIZED CHARACTER OF A MAMMARY TUMOR, METHOD AND KIT OF USE

Country Status (2)

Country Link
FR (1) FR2875512B1 (en)
WO (1) WO2006032769A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG139563A1 (en) * 2006-07-13 2008-02-29 Shimadzu Corp Diagnostic biomolecules
WO2023275322A1 (en) 2021-06-30 2023-01-05 University Of Limerick Gene signature for the identification of lymph node involvement in cancer patients

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69637552D1 (en) * 1995-03-17 2008-07-10 Wayne John Cancer Inst Detection of breast metastases using a multi-marker test
US20030158109A1 (en) * 2000-11-13 2003-08-21 Klaus Giese Metastatic breast and colon cancer regulated genes
US7171311B2 (en) * 2001-06-18 2007-01-30 Rosetta Inpharmatics Llc Methods of assigning treatment to breast cancer patients
FR2833968A1 (en) * 2001-12-20 2003-06-27 Ct Medico Chirurgical De Tronq Thematic biochip, useful e.g. for diagnosis, particularly of breast cancer, and treatment selection, comprises thematic probes and probes for interpretation
US20040191783A1 (en) * 2003-03-31 2004-09-30 Guy Leclercq Low density micro-array analysis in human breast cancer
TW200512298A (en) * 2003-09-24 2005-04-01 Oncotherapy Science Inc Method of diagnosing breast cancer

Also Published As

Publication number Publication date
WO2006032769A1 (en) 2006-03-30
FR2875512A1 (en) 2006-03-24

Similar Documents

Publication Publication Date Title
DE502005002436D1 (en) END-OF-SURGICAL BAG FOR THE RECORDING OF BODY TISSUE OR LIQUID
DE60206999D1 (en) Flow device for the destruction of microorganisms in fluids by means of ultrasound
DK3059322T3 (en) GENE EXPRESSION MARKERS FOR BREAST CANCER PROGRESS
DE602005011660D1 (en) Ultrasound probe and ultrasound machine
DE602004024630D1 (en) Ultrasonic diagnostic apparatus
DE602004023991D1 (en) Ultrasonic diagnostic apparatus
FR2894317B1 (en) CHUCK FOR USE IN A CIRCULATION CIRCULATION OF A FLUID AND ASSOCIATED FLUID OPERATING WELL.
NO20023402D0 (en) Mixtures and Methods for the Treatment and Diagnosis of Prostate Cancer
NO20030714L (en) Mixtures and Methods for the Treatment and Diagnosis of HER-2 / NEU-Associated Malignancies
DE60331861D1 (en) ULTRASONIC PROCEDURE AND ULTRASONIC UNIT
DE602005007134D1 (en) Ultrasound probe and ultrasound diagnostic apparatus
DK1342881T3 (en) Foamed acid treatment fluid
EP1756166A4 (en) Prostate cancer diagnosis and treatment
DK1678085T3 (en) Fluid treatment
DE602004029963D1 (en) Surgical ultrasound device
FR2875512B1 (en) DIAGNOSTIC BIOPUCE OF METASTATIC OR LOCALIZED CHARACTER OF A MAMMARY TUMOR, METHOD AND KIT OF USE
ITBO20030171A1 (en) GYMNASTIC TOOL FOR WALKING AND RUNNING EXERCISES.
DE602004022697D1 (en) ULTRASOUND DOPPLER BLOOD FLOW METER
GB0326578D0 (en) Cancer diagnosis and therapy
FI20021617A0 (en) Diagnostic and therapeutic procedures
MA26071A1 (en) FLUID VOLUMETRIC COUNTER
FR2868433B1 (en) METHOD FOR THE PROGNOSIS AND / OR DIAGNOSIS OF CANCER
AU2003294346A8 (en) Mammary fluid collection device and kit
ITBO20030237A1 (en) LOCALIZED WHIRLPOOL DEVICE.
FR2850886B1 (en) ATOMIZER - FRESH WATER OR REFRIGERATED HOT WATER FUMES AND ISOTHERMAL HUMAN BODY

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20120531